Play Your Way to the Malta Poker Festival $500k GTD with Intertops Poker
26.7.2019 17:17:00 EEST | Business Wire | Press release
How do you fancy winning a place at the Malta Poker Festival €500,000 GTD? Intertops Poker is giving you a chance to win a seat at the table via a number of satellite tournaments starting on 29th July.
The Malta Poker Festival €500,000 GTD takes place from 30th October – 4th November 2019 and as one of the Intertops Poker satellite winners you will receive a truly VIP stay during the tournament and that all important chance to take home the top prize.
The satellite winner package is worth €2,500 and includes:
- Buy-in to the MPF main event, Day1C, November 1st
- 5-night stay for two in a luxury room at the Hilton 5* Malta Resort
- Tickets for the exclusive MPF VIP Player party
- $500 to help with travel expenses
- Dinner with the Intertops Poker Team
- Intertops Poker Gear
Satellite tournaments will take place on the following days and at the following times between 29th July and 4th August 2019.
Malta Poker Festival €500,000 GTD Step 1 $2+$0.20
Daily, starting July 29th to August 3rd
starting times: 6:10pm / 12:10am / 6:10am / 12:10pm (all times in EDT)
(12:10pm / 6:10pm / 12:10am / 6:10am - all times in CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Step 2 guaranteed! »
Malta Poker Festival €500,000 GTD Step 2 $10+$1
Daily, starting July 29th to August 4th
starting times: 7:10pm / 1:10am / 7:10am / 1:10pm (all times in EDT)
(1:10pm / 7:10pm / 1:10am / 7:10am - all times in CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Final guaranteed! »
Malta Poker Festival €500,000 GTD - 'ULTIMATE' - FREEROLL
Sunday, August 4th at 2am EDT (8am CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Final guaranteed! »
Malta Poker Festival €500,000 GTD - Last Chance I - $8+$0.80
Sunday, August 4th at 5am EDT (11am CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Final guaranteed! »
Malta Poker Festival €500,000 GTD - Last Chance II - $8+$0.80
Sunday, August 4th at 8am EDT (2pm CEST)
« 1 ticket for Malta Poker Festival €500,000 GTD Final guaranteed! »
Malta Poker Festival €500,000 GTD Satellite Final $100+$10
Sunday, August 4th at 1:10pm EDT (7:10pm CEST)
« 1x Malta Poker Festival €500,000 GTD package guaranteed! »
In addition, if you would like to keep up to speed with all the action from the European Poker Championship from Casino Velden in Austria you can follow our daily updates and coverage here.
ENDS
Editor’s notes:
About Intertops Poker:
Intertops Poker
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190726005317/en/
Contact information
GameOn Marketing
Sarah Blackburn | Director | GameOn
0034628499459
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SES Launches Multi-Orbit Satellite Connectivity on LATAM Airbus, Embraer Fleet29.7.2026 18:30:00 EEST | Press release
SES, a leading space solutions company, was selected by LATAM Airlines to provide multi-orbit inflight connectivity service to its growing fleet of Airbus and Embraer aircraft, solidifying SES’s position as the top provider of multi-orbit broadband service in the Americas and around the world. “LATAM’s passengers will soon benefit from reliable, multi-orbit satellite connectivity that will provide the same fast and dependable internet access they enjoy at home no matter where or when they fly. SES’s partnerships with airlines like LATAM highlight how carriers throughout the Americas are leading the way when it comes to the most advanced connectivity. SES is a trusted partner that powers inflight connectivity,” said Mike DeMarco, SES President of Mobility. More than 60 Airbus (A320NEO and A321XLR) and Embraer aircraft (E195-E2) will be equipped with SES services in the coming years. LATAM will be the largest airline in the region to offer service using SES’s new electronically steered a
Carta Rearchitects Private Capital Operations with Plugins for Claude29.7.2026 17:01:00 EEST | Press release
Carta, the connected platform and AI-native ecosystem for private capital, today announces broad availability of its suite of Plugins for Claude following the initial launch in April 2026. With more than 1,500 companies and firms already using the plugins, Carta is changing the way private capital teams — from founders to CFOs — fundamentally operate, bringing fund administration, cap table management, and dealflow analytics directly into the spreadsheets, presentations, and workflows they already use every day. "For the last decade, private capital operation teams have been held back by a hidden tax: the constant, manual handoff of data between disconnected systems," said Henry Ward, Carta CEO. "Carta is eliminating that broken loop entirely by embedding intelligence directly into the tools teams already use. We are not waiting for an AI-native future for private capital — it is running on Carta today." Carta didn't just give Claude a pipe to its data. Carta built its private-capital
VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System29.7.2026 16:00:00 EEST | Press release
VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNova™ system. The randomized controlled study will compare TriNova head-to-head with the commercially available Edwards EVOQUE™ TTVR system. The TRIVITA trial (NCT07516444) initiation marks a significant milestone in advancing treatment for tricuspid regurgitation (TR). The prospective, global, multicenter, randomized (1:1) controlled study is designed to evaluate the safety and effectiveness of the TriNova TTVR system in patients with severe or greater tricuspid regurgitation who are suitable for valve replacement. The study will be conducted in the US and Europe with up to 70 sites participating. The first patient was enrolled at the Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, and tre
Grid Dynamics Accelerates Enterprise AI-Native Transformation With Workforce Certification and GAIN Platforms Rollout29.7.2026 16:00:00 EEST | Press release
Grid Dynamics Holdings, Inc. (Nasdaq: GDYN) (“Grid Dynamics”), a leading provider of technology consulting, platform and product engineering, and AI-driven digital transformation services, today announced significant momentum in the adoption of its enterprise agentic AI solutions. Organizations across retail, financial services, manufacturing, CPG, and logistics industries are increasingly deploying Grid Dynamics’ agentic AI-native platforms and Forward Deployed Engineering (FDE)-led services to accelerate software delivery, improve operational efficiency, and transform business processes at scale. Grid Dynamics is widely recognized for its enterprise AI expertise and delivery capabilities across Fortune 1000 organizations. Grid Dynamics has partnership agreements with Anthropic and OpenAI to accelerate the adoption of these platforms within enterprises. By the end of October 2026, Grid Dynamics plans to have 90% of its engineers trained and certified on these platforms. Built to suppo
VDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System29.7.2026 16:00:00 EEST | Press release
VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNova™ system. The randomized controlled study will compare TriNova head-to-head with the commercially available Edwards EVOQUE™ TTVR system. The TRIVITA trial (NCT07516444) initiation marks a significant milestone in advancing treatment for tricuspid regurgitation (TR). The prospective, global, multicenter, randomized (1:1) controlled study is designed to evaluate the safety and effectiveness of the TriNova TTVR system in patients with severe or greater tricuspid regurgitation who are suitable for valve replacement. The study will be conducted in the US and Europe with up to 70 sites participating. The first patient was enrolled at the Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital in Minneapolis, and tre
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom